These studies have shown that a low number of intratumoral CD8 + T cells and a large number of regulatory T cells are associated with a poorer prognosis in patients with HCC [58] and this stimulates the use of therapies that could re-educate an immune-reactive tumor environment, within the cancer environment, with a homeostatic immune loss. This evidence concerns the gene CD8A and hepatocellular carcinoma.